 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| CX-904 / CytomX, Amgen
New P1 trial, Metastases: A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors (clinicaltrials.gov) - May 23, 2022
P1, N=100, Recruiting, Sponsor: CytomX Therapeutics